Lytix Biopharma: CEO Presentation and Q&A
Research Interview
2024-04-22
14:51
CEO Øystein Rekdal gives an update on upcoming milestones including the Verrica phase 2 readout expected in Q2 and the ongoing capital raise.
TN
Thomas Nyberg
Disclosures and disclaimers